118 related articles for article (PubMed ID: 20506334)
21. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3.
Zhang CJ; Wang C; Jiang M; Gu C; Xiao J; Chen X; Martin BN; Tang F; Yamamoto E; Xian Y; Wang H; Li F; Sartor RB; Smith H; Husni ME; Shi FD; Gao J; Carman J; Dongre A; McKarns SC; Coppieters K; Jørgensen TN; Leonard WJ; Li X
Nat Commun; 2018 Jul; 9(1):2745. PubMed ID: 30013031
[TBL] [Abstract][Full Text] [Related]
22. Sialoadenitis in experimental graft-versus-host disease. An animal model of Sjögren's syndrome.
Fujiwara K; Sakaguchi N; Watanabe T
Lab Invest; 1991 Dec; 65(6):710-8. PubMed ID: 1753714
[TBL] [Abstract][Full Text] [Related]
23. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
24. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis of CD4+ T cells in Sjögren's syndrome: comment on the article by Zeher et al.
Kazkaz H
Arthritis Rheum; 2000 May; 43(5):1187-8. PubMed ID: 10817578
[No Abstract] [Full Text] [Related]
26. Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Arthritis Rheum; 2001 Feb; 44(2):490. PubMed ID: 11229485
[No Abstract] [Full Text] [Related]
27. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome.
Prochorec-Sobieszek M; Wagner T; Loukas M; Chwalińska-Sadowska H; Olesińska M
Med Sci Monit; 2004 Apr; 10(4):BR115-21. PubMed ID: 15039641
[TBL] [Abstract][Full Text] [Related]
28. Expression of the interferon-gamma-inducible 10-kd protein and CXC receptor 3 in the salivary gland lesions of patients with Sjögren's syndrome: comment on the article by Ogawa et al.
Sfriso P; Calabrese F; Grava C; Agostini C; Punzi L; Oliviero F; Botsios C; Ostuni PA; Todesco S
Arthritis Rheum; 2003 Aug; 48(8):2390-1; author reply 2391-2. PubMed ID: 12905497
[No Abstract] [Full Text] [Related]
29. SATB1 Conditional Knockout Results in Sjögren's Syndrome in Mice.
Tanaka Y; Sotome T; Inoue A; Mukozu T; Kuwabara T; Mikami T; Kowhi-Shigematsu T; Kondo M
J Immunol; 2017 Dec; 199(12):4016-4022. PubMed ID: 29127143
[TBL] [Abstract][Full Text] [Related]
30. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
31. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
[TBL] [Abstract][Full Text] [Related]
32. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
33. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
34. Genetic differences between primary and secondary sicca syndrome.
Moutsopoulos HM; Mann DL; Johnson AH; Chused TM
N Engl J Med; 1979 Oct; 301(14):761-3. PubMed ID: 314586
[No Abstract] [Full Text] [Related]
35. Familial abnormalities of lymphocyte function in a large Sjögren's syndrome kindred.
Jabs DA; Arnett FC; Bias WB; Beale MG
J Rheumatol; 1986 Apr; 13(2):320-6. PubMed ID: 3487648
[TBL] [Abstract][Full Text] [Related]
36. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
Hoffman RW
Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
[No Abstract] [Full Text] [Related]
37. [T and B cells and ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
Arimori S; Ichikawa Y; Takaya M
Nihon Rinsho; 1983; 41(2):446-9. PubMed ID: 6602896
[No Abstract] [Full Text] [Related]
38. Id3 knockout mice as a new model for sjogren's syndrome: only a T cell defect or more?
Versnel MA
Immunity; 2004 Oct; 21(4):457-8. PubMed ID: 15485622
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
40. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
